Clinical Trial Update: Sedative-Anxiolytic Effects on Simulated Driving Performance [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating sedative-anxiolytic effects on simulated driving performance in individuals with psychomotor impairment; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychomotor Impairment

Snippet

Sponsor: Marion Coe | Conditions: Psychomotor Impairment | Phase 4 | Status: COMPLETED | Results posted: 2020-01-29